Answers are grounded in this paper and cite their sources.
Research identifies molecular mechanisms in head and neck cancers, suggesting targeted treatments for better outcomes.
Head and neck cancers – especially head and neck squamous cell carcinoma – develop through a network of molecular aberrations, including faulty DNA repair, deregulated cell-cycle control, impaired apoptosis, and disrupted signaling for proliferation, invasion, and angiogenesis. These include frequent loss or mutation of tumor suppressors (e.g., tumor protein p53 [TP53] and cyclin-dependent kinase inhibitor 2A [CDKN2A]) and activation or amplification of oncogenes (e.g., phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [PIK3CA] and cyclin D1 [CCND1]), leading to abnormal growth and survival of malignant cells. Recognizing these molecular mechanisms paves the way for targeted strategies – such as inhibitors of DNA repair pathways, cell-cycle regulators, epigenetic modulators, or immune-based therapies – offering more tailored and potentially effective treatments.
No takes yet. Share an insight, caveat, or question.
B. Minu Chandra Muddabhaktuni (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: